Anthony Leo with Norgren explains multi-axis electric motion control technology and how it differs from more general electric motion control and pneumatic motion control technologies. Welcome to the ...
Increasing the number of axes in CNC machines raises the risk of vibration, especially with toolholding flaws like poor grip and high runout. High-precision toolholders significantly reduce runout, ...
Canada-based pipeline technology company TCI commissioned a high-speed robotic winding machine to wrap existing pipelines in carbon fibre in order to reduce the risk of leaks and enhance lifetime ...
You’ll soon be able to watch whatever you want side by side. You’ll soon be able to watch whatever you want side by side. is a news writer who covers the streaming wars, consumer tech, crypto, social ...
YouTube TV’s multiview feature will soon be “fully customizable,” letting viewers add any stream. Multiview has historically been limited to a relatively small selection of channels. YouTube TV will ...
A survey released Friday by corporate insurer Axis Capital shows there's a growing divide across the C-suite on how executives view the risks, rewards and impact of cutting-edge AI technology. The ...
Stage 3 multiple myeloma is defined by high beta-2 microglobulin, elevated LDH, and high-risk genetic abnormalities. Diagnosis involves CRAB criteria and tests like bone marrow biopsy, imaging, and ...
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient outcomes and possible cures. In this episode, experts discuss how bispecific ...
The segmentation details produced by different methods are shown in focus in the blue rectangular box areas. The proposed method performs better than other methods. Medical image segmentation is a ...
This morning, Donald Trump warned that the United States is "locked and loaded and ready to go" if Iran uses lethal force against protesters. At sea last month, a sanctioned tanker hauling roughly 300 ...
Key abstracts on multiple myeloma from the 2025 American Society of Hematology Annual Meeting are reported by Dr Joseph Mikhael, chief medical officer of the International Myeloma Foundation. Dr ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results